17 / 154
Speaker’s Biographies
Regarding elderly patients with lymphoma, I have studied the role of patients frailty in association with other prognostic
factor and therapy in defining patients’ outcome.
Currently I collaborate in the conduct of the Elderly Project study, that is a prospective registry of elderly patients with
lymphoma and I am Principal Investigator of phase II study investigating the clinical activity of chemotherapy regimen
with Obinutuzumab and miniCHOP for the treatment of elderly and UNFIT patients with DLBCL.
I am author and coauthor of 82 scientific papers published on the most relevant peer-reviewed journals of oncohematology.
My H-index is 24.
Other activities:
I am president of the GRADE onlus foundation (Gruppo Amici Dell’Ematologia), non profit association with the aim to
support activities and staff of the Department of Hematology Arcispedale Santa Maria Nuova - IRCCS of Reggio Emilia,
funding research projects and assistance for patients with haematological cancers diseases.
Speaker Abstract(s): S39
Stefania Migliuolo
Europa Donna, Milan, Italy
Classically trained as MD with a Board certificate in Pediatrics. Clinical practice as pediatric oncologist followed by ten
years pharma industry experience in health marketing. Since 15 years, she moved into Healthcare communication.
She is volunteering in Europa Donna Italia, an independent non-profit organisation. Europa Donna objectives are to raise
awareness in breast cancer prevention and treatment, helping women to cope with this condition across 46 countries
and to represent the interests of European women regarding breast cancer to local and national authorities as well as to
institutions of the European Union.
Speaker Abstract(s): S40
Olivier Mir
The speaker biography has not been received at the time of publication.
Speaker Abstract(s): S41
Nicolas Mottet
Urology department, 42025, St Etienne, France
Professor Nicolas Mottet, MD, PhD is Head of the Urology Department, University Hospital, and Professor of Surgery,
University Jean Monnet, Saint-Etienne, France. He is board certified in surgery, urology and medical oncology. He is
chairman of the EAU Working Group on Prostate Cancer Guidelines, board member of the Urology Group for the French
Anti-Cancer Centre Federation, and member of the SIOG prostate and bladder cancer guidelines. He is the former
coordinator the Testis and Penile Cancer Subgroup (French Urological Association 2000–2008). He has published over
160 peer-reviewed papers and made numerous presentations and lectures; he is member of the Editorial Board of the
European Urology Journal and a reviewer of more than a dozen of high profile journals including the New England
Journal of Medicine. He sits on the scientific advisory board of several multinational pharmaceutical companies. He
coordinated or participated to more than 40 clinical trials and received several national grants. He is member of the
AUA, AFU, ASCO, EAU, ESMO and SIOG.
Loïc Mourey
Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Medical Oncology, Toulouse, France
Dr Loïc Mourey is Medical Oncologist in the comprehensive cancer center of Toulouse, in south west of France. His main
topics are genito-urinary cancers and geriatric oncology. In France, he is an active member of groups involved in geriatric
Oncology: GERICO, intergroup DIALOG, SoFOG. At the regional level, he is the co-coordinator of the Midi-Pyrénées
UCOG (Unité de Coordination en Onco-Gériatrie).
Speaker Abstract(s): S42
Arash Naeim
David Geffen School of Medicine, Department of Medicine, Los Angeles, CA, USA
Dr. Naeim is a Professor of Medicine in both Divisions of Hematology-Oncology and Geriatric Medicine at the UCLA
David Geffen School of Medicine. He is an Assistant Vice Chancellor of Research, Associate Director for the Clinical
Translational Science Institute, and Chief Medical Officer for Clinical Research for the UCLA Campus and Health
System. His research interests included outcomes research, cost-effectiveness analysis, modeling of health and frailty,
and clinical trial design in older cancer patients. His focus of research for the majority of his publications and research
grants has been in breast cancer and cancer in the elderly. He is the UCLA Principal Investigator for the Athena Breast
Health Network and NIH grant that aims to use sensor technology and analytics to reduce risk, integrate innovative
technology, and advance precision medicine in older individuals needing rehabilitation.